NIH-funded research NIH-funded research

Cervical cancer screening and treatment rollout in resource-poor settings

Official title: Administrative and Engagement Core

Funded at Columbia University Health Sciences · NIH-11644471 · Data updated 2026-11-12

A team from Columbia and the University of Cape Town is testing how to best implement affordable, same-day HPV-based screen-and-treat for cervical cancer in public health settings.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionColumbia University Health Sciences
NIH-funded
Lab location1 site (New York, United States)
Project startSeptember 19, 2023
Project endAugust 31, 2028
Funding year2026
Award (this year)$353,171
NIH project number3U54CA284030-04S1
Project IDNIH-11644471 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are individuals in the target population for cervical cancer screening programs within resource-constrained settings, particularly in public health clinics.

Less likely to help

Patients in settings with already optimized HPV-based screen-and-treat workflows may see limited additional benefit.

What this research studies

This project builds on nearly 30 years of collaboration to speed up the use of HPV-based screen-and-treat for cervical cancer in South Africa. It focuses on how to operationalize and scale up evidence-based HPV screening in real-world clinics, with on-site treatment and focused implementation support. Through the Empilisweni Initiative, the team will work with local health authorities, researchers, and communities to improve coordination, decision-making, and knowledge sharing to reach more women. The effort includes building local capacity and adapting strategies to resource-limited settings to accelerate cervical cancer control.

Why it matters

Potential benefit: If successful, the project could help more women in resource-limited areas get timely cervical cancer screening and treatment, reducing disease burden.

How similar studies have gone: Previous trials and national guidelines support HPV-based screen-and-treat; this project focuses on implementation and scale-up in real-world settings.

Where this research is happening

  • Columbia University Health Sciences
    New York, United States
    Active

Researchers

  • Principal investigator: Castor, Delivette — Columbia University Health Sciences
  • Study coordinator: Castor, Delivette

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.